Skip to main content
OpenTrials
Completed

NCT Number: NCT02689648

Long Term Follow up on Functional Gastrointestinal Disorder (FGID)

Long term prognosis and risk factors in functional gastrointestinal disorder (FGID) is largely unknown. The investigators plan to retrospectively analyse a cohort of children who were referred to the Pediatric Clinic due to abdominal pain with the aims to learn more about symptoms and effects of investigations performed. Furthermore, the investigators plan to contact the cases for a follow up using a validated questionnaire and analyse the long term prognosis and risk factors for prolonged severe symptoms.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Umeå University, Department of Clinical Sciences

Umeå, 90185, Sweden

About this study

Long term prognosis and risk factors in functional gastrointestinal disorder (FGID) is largely unknown. The investigators plan to retrospectively analyse a cohort of children who during the years 2010-2015 were referred to the Pediatric Clinic of Umeå University Hospital due to abdominal pain. The aims are to explore and descriptively describe the symptoms and effects of investigations performed. Furthermore, the investigators plan to contact the cases five years after the first contact for a follow up using a validated questionnaire of the ROME-III-criteria and analyse the long term prognosis and risk factors for prolonged severe symptoms.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

At time of first visit the children had:

  • At least 2 months of abdominal pain
  • Age 3-18 years
  • No organic gastrointestinal diseases
  • No neuromuscular disease

Treatment and study plan

Primary outcomes

  1. Percentage (%) of patients that fulfill the ROME-III criteria for FGID

    Time frame: 5 years after fist visit +/- 1 year

    Measured by the validated ROME-III questionnaire

Secondary outcomes

  1. ICD 10-diagnosis following the primary investigation

    Time frame: 12 months after first visit

  2. Current ICD 10-diagnosis

    Time frame: 5 years after fist visit +/- 1 year

  3. Number (n) of visits for the primary investigations

    Time frame: 0-12 months after first visit

Sponsors and collaborators

Lead sponsor

Umeå University

Other

Registry information

Acronym: LUFT

Important dates

Study start
2016
Primary completion
2025
Study completion
2025
First posted
Feb 24, 2016
Registry last updated
May 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.